ReNeuron Group PLC (RQE.L)

Pharmaceuticals - Generic & Specialty

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Share Price

Share Intraday Performance
- ( - )
Bid: 3.3p Offer: 3.8p
As of: 01 Apr 2015 16:26
Market Capitalisation: £62.61 million
Shares In Issue: 1,788.83 million
PE: 0
Dividend Yield: 0

Share Performance

52 week high:   4.4p on 02-Dec-14
52 week low:   2.9p on 16-Jun-14

Financial History

to Mar '12to Mar '13to Mar '14
Operating Profit-£7m-£7m-£8m
Total Operating Expense£7m£7m£8m
Net Profit-£6m-£6m-£7m
Net Profit Before Taxes-£7m-£7m-£8m
Net Profit After Taxes-£6m-£6m-£7m

Sponsored by:

Company Information
Number of Shares Out 1,788.83m
Number of Shares Floating 1,572.10m
Number of Common Share Holders
Number of Employees 27
Key Figures
Volume (10 day Avg.) 1.44822m
Turnover £0.02m
Profit Before Tax £-7.07m
EPS -0.50p
Cashflow Per Share -0.49p
Cash Per Share 1.17p